October 31, 2002
"The state will pay for medicine, test costs and any necessity for additional staff," Siegel said in announcing the agreement, which extends the CMS contract with the state until Aug. 31, 2003. The money for hepatitis C treatment will be in addition to the millions of dollars the state pays CMS. It was unclear, Siegel said, how much extra money the state would need to spend. Other state corrections departments are finding it can cost $15,000 to $25,000 per hepatitis C-infected inmate to cover testing, monitoring and treatment. The drugs cure about half of treated patients, with viral levels dropping to undetectable levels and remaining there.
New Jersey's current contract with CMS expires today, and the state had received no bids it considered acceptable for a new contract. CMS had asked for an increase that would have raised the cost of prison health care by 30 percent to more than $100 million annually, but it said the state would have to pay extra for hepatitis C care. The state rejected that proposal, arguing that hepatitis C care should have always been covered under the contract. Under the 10-month extension, Siegel said, CMS will receive a 14.7 percent increase.
Like other states, New Jersey is facing epidemic levels of hepatitis C infection among inmates. Nationally, 20-30 percent of prisoners are infected with the blood-borne virus. In Georgia, the annual budget for hepatitis C treatment could eventually approach $5 million, said Joseph Paris, the state's prison medical director.
10.31.02; Mark Fazlollah; Jennifer Lin
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|A Review of Late-Stage HIV Antiretroviral Candidates at IDWeek 2017|
|'Caring at Its Essence': HIV Nurses Recall Pivotal Moments With Patients|
|PrEP Prescriptions Rise Sharply, but Unequally, in New York City|
|How to Reverse Implicit Bias in HIV Care: 6 Steps to Take Today|
|In Their Words: Burdens of HIV Nursing Include Lack of Respect and Resources|
|Conversations With Federal HIV Leaders From the 2017 U.S. Conference on AIDS|